TrialDiabetes, obesity & metabolism2019

Fast-acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose-lowering effect compared with insulin aspart.

Thomas R Pieber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.